Obesity hypoventilation syndrome (OHS) is not simply severe obstructive sleep apnea. It is diagnosed when a person has obesity, sleep-disordered breathing, and elevated arterial carbon dioxide while awake, and another lung, neuromuscular, chest-wall, metabolic, medication-related, or central cause does not better explain the hypoventilation 12.
In the standard adult definition, obesity means a body mass index (BMI) of at least 30 kg/m² and awake hypercapnia means an arterial carbon dioxide pressure (PaCO2) of at least 45 mm Hg at sea level 1. BMI is only one diagnostic component. Body size, snoring, sleepiness, a low oxygen reading, or an elevated bicarbonate result cannot establish OHS on its own.
OHS is treatable, but untreated ventilatory failure can strain the heart and lungs and can progress to an acute respiratory emergency. The useful next step is timely blood-gas and sleep evaluation, not trying to diagnose carbon dioxide retention with a watch or home oximeter 3.
What hypoventilation means
Ventilation is the movement of air needed to remove carbon dioxide. In hypoventilation, breathing does not clear enough carbon dioxide for the body's current production. This is about the effectiveness of breathing, not just the respiratory rate. Someone can breathe at an apparently ordinary rate and still move too little air with each breath.
OHS develops through a combination of factors. Obesity can increase the mechanical load on the chest and abdomen, lower some lung volumes, and increase the work of breathing. Sleep-related airway obstruction or sustained underbreathing can add repeated nighttime carbon dioxide elevations. People who develop OHS also have an inadequate ventilatory response to that load. No single hormone, airway feature, or behavior explains every case 2.
OHS is different from these related conditions
Obstructive sleep apnea
In obstructive sleep apnea (OSA), the upper airway repeatedly narrows or closes during sleep. Daytime PaCO2 can remain normal. Most people with OHS also have OSA, and more than 70% have severe OSA, but the defining awake hypercapnia makes OHS a separate diagnosis 1.
This difference affects treatment. CPAP can be a suitable first treatment when severe OSA is the dominant sleep pattern, but some people need non-invasive ventilation to support ventilation as well as hold the airway open.
Isolated sleep-related hypoventilation
Carbon dioxide can rise during sleep before it remains elevated while awake. A person with obesity and nocturnal hypoventilation but normal awake PaCO2 does not yet meet the usual OHS definition. The nighttime finding still deserves evaluation and treatment based on its cause and severity.
COPD and OSA overlap
COPD can itself cause chronic carbon dioxide retention. COPD with OSA is commonly called COPD-OSA overlap syndrome. If lung disease adequately explains the awake hypercapnia, labeling the problem as OHS alone is inaccurate. Some people have more than one contributor, so clinicians interpret spirometry, imaging, history, blood gases, and the sleep pattern together.
Neuromuscular, chest-wall, metabolic, and medication causes
Weak breathing muscles, disorders affecting their nerve supply, substantial chest-wall restriction, severe hypothyroidism, and central hypoventilation disorders can produce a similar blood-gas pattern. Opioids, sedatives, anesthetics, and other respiratory-depressing medicines or substances can also cause or worsen hypoventilation 24.
OHS is therefore a diagnosis of exclusion. This does not mean every person needs every possible test. The history and initial findings decide which alternatives need to be investigated.
Acute respiratory failure
OHS is a chronic diagnosis, but it may first be recognized during acute-on-chronic hypercapnic respiratory failure. In that situation, carbon dioxide rises enough to disturb acid-base balance or mental status, oxygen may fall, and urgent ventilatory support may be needed. Acute treatment must not wait for a routine outpatient sleep workup 5.
Symptoms raise suspicion, but do not diagnose OHS
Possible symptoms include:
- breathlessness, reduced exercise tolerance, or fatigue - daytime sleepiness or difficulty staying alert - morning headaches - loud snoring, witnessed pauses, choking, or gasping during sleep - unrefreshing or disrupted sleep - ankle swelling, which can accompany heart or pulmonary complications
These symptoms are nonspecific. OSA without OHS, insufficient sleep, anemia, heart or lung disease, medicine effects, and many other conditions can look similar. Some people with substantial chronic hypercapnia report few symptoms. NHLBI advises reporting new ankle swelling, chest pain, lightheadedness, or wheezing rather than assuming it is part of an established sleep problem 3.
Severe daytime sleepiness also creates an immediate driving and workplace risk. Do not drive when you are struggling to stay awake 6. As a practical extension, do not operate hazardous equipment in that state either, regardless of whether OHS has been confirmed.
How OHS is diagnosed
1. Estimate the likelihood from the full picture
A clinician reviews sleep and breathing symptoms, BMI, oxygenation, previous respiratory admissions, current illnesses, and every prescribed, over-the-counter, and nonprescribed substance that could affect breathing. A prior OSA diagnosis does not settle the question because OSA testing alone does not measure awake PaCO2.
2. Use serum bicarbonate as a screening clue
The kidneys retain bicarbonate when carbon dioxide has been elevated over time. In someone with a low or moderate pretest probability of OHS, the American Thoracic Society suggests that serum bicarbonate below 27 mmol/L can make OHS unlikely. If it is 27 mmol/L or higher, PaCO2 should be measured rather than treating the bicarbonate result as a diagnosis 1.
A positive bicarbonate screen is not specific. Diuretics and other acid-base disturbances can raise it. When the clinical suspicion is high, guidelines favor measuring PaCO2 directly rather than using bicarbonate to decide whether testing is needed 1.
3. Confirm awake hypercapnia with a blood gas
An arterial blood gas obtained while awake is the standard way to confirm PaCO2 and assess oxygen and acid-base status. NICE also recognizes an arterialized capillary blood gas performed through an appropriate clinical protocol 5. A routine venous chemistry carbon dioxide value, pulse oximeter, or wearable cannot replace this measurement.
Pulse oximetry measures oxygen saturation, not carbon dioxide. A low reading can have many causes, and a reassuring reading does not prove that ventilation and PaCO2 are normal. Home devices can help a clinician monitor a defined question, but they cannot confirm or exclude OHS.
4. Define the breathing pattern during sleep
Polysomnography or respiratory polygraphy identifies whether the main sleep pattern is frequent obstructive events, sustained hypoventilation, or both. Transcutaneous carbon dioxide monitoring may be added to show the extent of nocturnal hypoventilation and help select treatment 5. Overnight oximetry alone cannot make the full distinction.
5. Exclude a better explanation
Testing is individualized. It may include spirometry or other pulmonary function tests, chest imaging, thyroid testing, neuromuscular evaluation, and assessment for heart failure or pulmonary hypertension. A careful medicine and substance review is essential. The goal is not to order a fixed panel but to establish why awake hypercapnia is present.
Treatment matches the clinical setting and sleep pattern
Positive airway pressure is core treatment
The ATS guideline suggests positive airway pressure (PAP) during sleep for stable ambulatory OHS, although the certainty of evidence for several treatment choices remains low 1. PAP is an umbrella term that includes CPAP and forms of non-invasive ventilation (NIV).
- CPAP provides a continuous pressure that holds the upper airway open. For stable OHS with severe OSA, ATS and NICE recommend CPAP as the usual first treatment 15.
- NIV provides additional inspiratory support and may include a backup rate or volume-targeted features. NICE recommends considering NIV when OSA is absent or not severe, nocturnal hypoventilation predominates, or CPAP is poorly tolerated or fails to improve symptoms, hypercapnia, obstructive events, or oxygenation 5.
NIV is not automatically "stronger CPAP," and a brand term such as BiPAP does not describe every ventilator mode. Device, mode, pressures, backup settings, interface, and any oxygen connection require specialist selection and titration. Do not copy another person's settings or change pressure, backup rate, target volume, or oxygen flow on your own.
Follow-up checks ventilation, not only usage hours
NICE recommends an initial review within one month, followed by visits according to need until symptoms, obstructive events, oxygenation, and awake and asleep hypercapnia are controlled. Review should also include actual device use, leak, mask fit, comfort, and available download data 5.
Persistent sleepiness, headaches, breathlessness, low oxygen, or high PaCO2 can reflect inadequate use, leak, an unsuitable mode or setting, another illness, or a treatment that needs more time. The answer is a clinician-led reassessment, not a home pressure experiment. Once treatment is stable, ongoing follow-up remains necessary.
Oxygen treats hypoxemia, not hypoventilation
Supplemental oxygen may be added when hypoxemia persists after CPAP or NIV has adequately controlled obstructive events and nocturnal hypoventilation. Additional causes of low oxygen should also be assessed 5.
Oxygen alone does not move more air or clear carbon dioxide. In a small randomized crossover trial, breathing 100% oxygen for 20 minutes raised transcutaneous carbon dioxide in adults with untreated obesity-associated hypoventilation, and three of 24 participants stopped early after a rise of at least 10 mm Hg 7. This does not mean oxygen should be withheld during an emergency. It means oxygen for OHS should be prescribed and monitored with attention to ventilation and carbon dioxide, often alongside NIV in acute hypercapnic failure.
Do not start, stop, or change prescribed oxygen based only on a home saturation number.
Weight management is disease care, not a substitute for breathing support
PAP treats sleep-disordered breathing and ventilatory failure now. Weight-management treatment addresses an important contributor over a longer period. Neither should be delayed while waiting for the other.
The ATS guideline suggests interventions capable of sustained 25% to 30% total body-weight loss because that range is most likely to resolve hypoventilation. The recommendation is conditional and based on very-low-certainty evidence, and the guideline acknowledges that many people cannot reach or sustain that amount through lifestyle intervention alone 1.
Care may include nutrition support, activity adapted to breathing and mobility, behavioral care, anti-obesity medication, or evaluation for metabolic or bariatric surgery. The appropriate combination depends on health conditions, access, preferences, expected benefit, and risk 3. OHS is a physiological disease, not evidence of weak character or poor commitment.
Weight loss can improve ventilation without guaranteeing that OHS or OSA has resolved. Continue PAP unless the treating team repeats the relevant blood-gas and sleep assessment and advises a change 5.
Medicines, surgery, pregnancy, and travel
Medicines and substances
Give the treating team a complete list of opioids, benzodiazepines, sleep medicines, muscle relaxants, alcohol, cannabis, and other sedating substances. These can compound hypoventilation or mask worsening sleepiness. Do not abruptly stop a prescribed opioid, benzodiazepine, or other medicine because withdrawal can also be dangerous. Ask the prescriber how to reduce respiratory risk 4.
Respiratory stimulants are not routine substitutes for PAP. If one is considered in a specialized setting, it still does not replace ventilation assessment and follow-up 2.
Surgery and sedation
OHS raises perioperative risk because anesthesia, sedatives, opioids, airway difficulty, and postoperative oxygen can interact with an already limited ventilatory reserve. A 2024 clinical review highlights increased risks of postoperative respiratory failure and opioid-related respiratory depression 4.
Tell the surgeon, anesthesiologist, and recovery team about known or suspected OHS before any procedure using sedation or anesthesia. Bring the PAP or NIV device if instructed, and ask when it should resume after the procedure. A normal home oximeter reading does not replace a perioperative plan.
Pregnancy
NICE lists pregnancy as a reason to prioritize rapid sleep-service assessment when OHS is suspected 5. PAP, oxygen, medicines, and delivery planning should be coordinated between respiratory, sleep, and obstetric teams. Do not change ventilator or oxygen settings without that team.
Flying
NHLBI advises people with OHS to discuss flying with their clinician because it may increase the risk of complications 3. Ask well before travel whether PAP or NIV can be used in flight and whether a formal oxygen assessment or airline documentation is needed. Do not infer fitness to fly from a resting home saturation reading.
Hospital treatment and discharge are different from routine home care
Acute hypercapnic respiratory failure is treated in a monitored medical setting. NIV is commonly used after the airway, oxygen, infection, fluid status, medicines, and other triggers are assessed. Someone who is confused, difficult to wake, or struggling to breathe should not be placed on an unfamiliar home device while waiting to see whether it helps 5.
For a person hospitalized with respiratory failure and suspected OHS, the ATS guideline suggests discharge with NIV until outpatient diagnostic workup and PAP titration can occur, ideally within three months. It explicitly states that temporary discharge NIV does not replace arranging that evaluation 1.
After stabilization, the long-term mode may change. Respiratory polygraphy can show whether severe obstructive events with minimal residual hypoventilation make a supervised CPAP trial appropriate, or whether NIV should continue 5.
Get emergency help for possible respiratory failure
Call emergency services for:
- rapidly worsening breathlessness, air hunger, or inability to speak normally because of breathing difficulty
- blue or gray lips, face, or fingertips - new confusion, disorientation, extreme drowsiness, inability to stay awake, or loss of consciousness
Low oxygen can cause air hunger, drowsiness, and bluish discoloration. High carbon dioxide can cause headache, confusion, rapid breathing, extreme sleepiness, and loss of consciousness. Acute respiratory failure can be life-threatening and needs rapid hospital treatment 8.
If symptoms are not an emergency but morning headaches, breathlessness, ankle swelling, sleepiness, or PAP problems are increasing, contact the sleep or respiratory service promptly. OHS decisions depend on measured ventilation, the sleep pattern, and the person's response to treatment, not a single symptom or consumer-device score.
